Gene Architect is progressing from experimental research toward a protected, measurable and computational platform.
01 — SCIENTIFIC FOUNDATION Peer-reviewed research in small non-coding RNA–mediated regulatory modulation.
02 — PROTECTED IP Patent WO2022053130 provides an established intellectual-property foundation.
03 — EXPERIMENTAL PLATFORM Quantitative cellular morphology and phenotypic-state analysis are now being integrated into the Gene Architect computational framework.
04 — AI PILOT First pilot AI model targeted for Q4 2026 / Q1 2027.
SOVEREIGN CORE. GLOBAL REACH.
A protected core under sovereign-level security, connected to specialized international hubs for research, validation and translation.
Gene Architect is designed not as a single intervention, but as a closed-loop infrastructure — connecting biological measurement, computational intelligence, individualized regulatory design and controlled implementation.